Prolastin-c
Ended Awarded Last action
- Contract number
- 36C26024F0074
- Awardee
-
Grifols USA LLC UEI D48FNWJCJ5H5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $96,618
Award facts
- Contract value 100% obligated
- $96,618.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Los Angeles, CA 90032, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$12,582 | |
| Original award | $109,200 |
About this award
On February 8, 2024, the Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a delivery order valued at $96,618.03 to Grifols USA LLC for PROLASTIN-C, an alpha1-proteinase inhibitor pharmaceutical product used to treat alpha1-antitrypsin deficiency. This firm fixed-price delivery order, which will be completed by February 8, 2025, was issued without a set-aside designation and represents performance under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The place of performance is Los Angeles, California, where Grifols USA LLC manufactures and distributes its specialized pharmaceutical products.
Grifols USA LLC is a global healthcare manufacturer with extensive experience supplying critical pharmaceuticals to federal agencies, particularly the Department of Veterans Affairs. The company holds substantial federal contract vehicles, including a $1.38 billion VA Federal Supply Schedule contract for pharmaceuticals and drugs and a $107.5 million blanket purchase agreement specifically for PROLASTIN-C products. This delivery order is consistent with Grifols' established role as a primary supplier of specialized plasma-derived medicines and pharmaceutical products within the federal healthcare procurement system.
Quick answers
Who was awarded contract 36C26024F0074?
36C26024F0074 was awarded to Grifols USA LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on February 8, 2024.
How much is contract 36C26024F0074 worth?
The government has obligated $96,618 on 36C26024F0074.
Is contract 36C26024F0074 an order under another contract?
Yes. 36C26024F0074 is a delivery order under 36F79722D0090, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0074 competed?
The extent of competition for 36C26024F0074 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award